Physician profile
Luke Barnard
NPI 1710543111
$4,143.37
in general payments reported to CMS, 2019-2025
14 companies · $2,717 in 2025
The $2,717 reported for 2025 was more than what 86% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $396 · 2024: $1,030 · 2025: $2,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,143.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $685.18 | 2024-2025 | Tepezza, Otezla |
| Bausch & Lomb Americas INC. | $675.45 | 2023-2025 | Envista Envy Iol, Stellaris, Envista Mx60 Iol |
| Glaukos Corporation | $588.52 | 2024-2025 | Idosetr, Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $436.00 | 2024-2025 | Clareon, Hydrus Microstent, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $345.31 | 2025 | Xdemvy |
| Genentech USA, INC. | $293.86 | 2023-2024 | Vabysmo |
| Rxsight INC | $282.33 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Contact Lens |
| Abbvie INC. | $216.60 | 2024-2025 | |
| Sight Sciences, INC. | $200.34 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Mallinckrodt Hospital Products INC. | $194.80 | 2025 | Acthar |
| Glaxosmithkline, LLC. | $93.39 | 2025 | Blujepa |
| Sun Pharmaceutical Industries INC. | $81.11 | 2025 | |
| New World Medical,INC. | $27.79 | 2024 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Oyster Point Pharma, INC. | $22.69 | 2025 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Barnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.